Apr 01, 2019

Huntsman Cancer Institute Contributes to Colorectal Cancer Research Studies

Huntsman Cancer Institute contributed to two research studies involving how microbes living in and on our body play a role in the development of colorectal cancer.

Mar 28, 2019

Letter of Hope from the Ulrich Group

We can only imagine how hard it must be for patients, along with their caregivers and loved ones, to hear they have cancer. Our shared purpose is to make it so no one has to experience these difficult emotions in the future by researching how to prevent cancer before it happens.

Mar 22, 2019

Huntsman Cancer Institute Researchers Appointed to National Scientific Leadership Roles

Huntsman Cancer Institute's CEO, Mary Beckerle, PhD, and Senior Director of Pre-Clinical Translation, Martin McMahon, PhD, have been appointed to prominent national advisory boards within the National Institutes of Health to provide expert advice on national cancer research initiatives.

Mar 01, 2019

Advancing Hematologic Cancer Research and Care

The Center of Excellence in Hematologic Malignancies and Hematology at Huntsman Cancer Institute is a group of more than three dozen doctors and scientists dedicated to hematologic cancers such as leukemia, lymphoma, and multiple myeloma. Integration and collaboration across disciplines will improve clinical care and advance research in these complicated diseases.

Mar 01, 2019

Clinical Trials: A Look at Recent Progress

Clinical trials test the safety and effectiveness of new cancer drugs and treatments. They help us find better ways to prevent, diagnose, or treat cancer. At any given time, Huntsman Cancer Institute has an average of 200 clinical trials open to cancer patients.

Mar 01, 2019

Meet Our Trainees

Faculty at Huntsman Cancer Institute cultivate the scientists who will carry our lifesaving work into the future. It’s part of our mission. We offer trainee programs for researchers, public health professionals, and care providers such as physicians and advanced practice clinicians. These are some of the more than 425 students training at HCI.

Mar 01, 2019

Finding Familial Cancer Risk

In 2018, a team of researchers at Huntsman Cancer Institute received a prestigious National Cancer Institute Cancer Moonshot grant. The grant will fund studies about ways to identify patients who may benefit from genetic counseling and services.

Mar 01, 2019

Pancreas Discovery Moves from Lab to Clinic

In less than three years, HCI researchers have taken an idea from concept to lab to clinical evaluation. Conan Kinsey, MD, PhD, and Martin McMahon, PhD, combined two drugs that had not been used in combination before to treat pancreatic tumors. The results were promising and they were able to move from the lab to clinical trial quickly. A clinical trial to test the safety and effect of this drug combination in pancreatic cancer is now underway at HCI and planned at other sites around the United States.